Is there a particular probiotic that is better for anxiety and depression?

The gut-brain axis refers to the bidirectional communication network between the central and autonomic nervous systems and the intestines. Gut-brain communications are mediated by the immune system, endocrine (hormone) connections such as the hypothalamic-pituitary-adrenal (HPA) axis, and neural pathways involving the enteric nervous system and vegas nerve.  The gut-brain axis is now thought to be critical in our understanding and treatment of depression and anxiety, and as clinical trials validating these concepts have begun to emerge in the last decade, a new class of probiotics also emerged – the so-called psychobiotics, or psychomicrobiotics – which hold significant promise for new, nontoxic treatment of psychiatric disorders.

Target gb-X by Klaire Labs with Ecologic BARRIER is a unique 9-strain probiotic blend formulated to support positive mood and address those with depression and anxiety. This shelf stable, 5 billion CFU probiotic was specifically designed to influence the gut-brain axis through defined mechanisms. Preclinical and human RCT trials have demonstrated that this probiotic formula specifically acts on the gut-brain axis through strengthening gut barrier function, decreasing inflammatory cytokines and proteins such as lipopolysaccharide (LPS) and zonulin endotoxins, encouraging the production of neuroprotective metabolites, and a marked reduction in transcription of hippocampal genes related to HPA dysregulation.

The gut-brain axis is a fascinating field of research, and Klaire Labs is on the front lines of innovative probiotic formulation to address such concerns.  Thus, Target-GBX would be a great choice for those with depression and anxiety and due to is mechanisms of restoring tight-junction integrity and protecting of intestinal barrier function, it has a broad range of applications including those with increased intestinal hyperpermeability (leaky gut) and HPA axis dysregulation or adrenal fatigue.

  1. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203-209.
  2. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12(8):453-466.
  3. Moloney RD, Desbonnet L, Clarke G, et al. The microbiome: stress, health and disease. Mamm Genome. 2014;25(1-2):49-74.
  4. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-712.
  5. Collins SM, Kassam Z, Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol. 2013;16(3):240-245.
  6. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-312.
  7. Lyte M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLOS Pathog. 2013;9(11):e1003726.
  8. Van Hemert S, Ormel G. Influence of the multispecies probiotic Ecologic BARRIER on parameters of intestinal barrier function. Food and Nutrition Sciences. 2014;5:1739-1745
  9. Steenbergen L, et al. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015;48:258-64.